After bull
run on Friday and making record high Indian Stock market took pause for the day ,looks like hangover of
weekend. Sensex dip by 168 point and took closing at 71315 on the same hand NSE
Nifty down by 38 point and closed at 21418, sector Infra , metal and pharma were gainer for the
day on the same hand Cement , banking and reality push Indian stock market to
down side
GAINERS
IRCTC 12.59 % , SIEMENS 5.94 % , ZYDUS LIFE 5.37 %
GODREJ PROP
3.08% , INDIACEM 2.33 % , POWERGRID 2.32 %
SHORT NEWS
1. Vedanta
approves second interim dividend of Rs 11 per share for FY24
2. SpiceJet, 2 others in
race to bid for bankrupt Go First; share price surges 20%
3. Mankind Pharma gains on raising stake in British therapeutics firm
Mazagon Dock Shipbuilders: The shipbuilding company has signed individual shipbuilding contracts with the European client for construction of three units of 7,500 DWT multi-purpose hybrid powered vessels. The contract is valued at approximately $42 million.
Adani Enterprises: Subsidiary AMG Media Networks has acquired a
50.50 percent stake constituting equity shares (Category I shares with voting rights) and equity shares (Category II shares without voting rights) each of IANS India for Rs 5.1 lakh. AMNL has also signed a shareholders’ agreement with IANS and Sandeep Bamzai, a shareholder of IANS.
PB Fintech: Softbank has sold 1,14,21,212 equity shares in the Policybazaar operator via open market transactions. Softbank offloaded these shares at a price of Rs 800.05 per share, valued at Rs 913.75 crore.
PVR INOX: Plenty Private Equity Fund I, and Plenty Private Equity FII I have offloaded 18,38,757 equity shares or 1.87 percent of paid-up equity in the multiplex chain via block deals, at a price of Rs 1,753 per share.
PSU banks: A government document shared on social media has triggered speculation about possible PSU bank mergers between Union Bank and UCO Bank, and Bank of India and Bank of Maharashtra.
Sugar stocks in focus: The food ministry has issued a fresh order reversing the
ban on the use of sugarcane juice for making ethanol and allowing the use of
the juice as well as B-heavy molasses to produce the green fuel in the 2023–24
supply year. In a directive issued to all sugar mills and distilleries, the
ministry said the oil marketing companies (OMCs) will issue a revised
allocation of sugarcane juice and B heavy molasses-based ethanol for the
2023–24 supply year to each distillery.
WelspunCorp: The pipe solutions provider said its subsidiary Sintex BAPL has finalised an investment of up to Rs 807 crore to set up a manufacturing unit in Telangana through a wholly owned step-down subsidiary, Sintex Advance Plastics (SAPL). This investment will be spread over the next three financial years, starting in FY25. The project will be funded through a combination of debt and equity. The proposed investment is for manufacturing 59 KMTPA of plastic pipes, 5,300 MTPA
of water storage tanks, and 8,900 MTPA sandwich-moulded tanks.
Zydus Lifesciences: The pharmaceutical company has received permission from the USFDA to initiate the Phase II clinical study of the NLRP3 inhibitor ZYIL1 in patients with Parkinson’s disease. Parkinson’s is a disease in which patients steadily lose control over their movements. In addition, the firm has also received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Lacosamide tablets. Lacosamide is indicated to treat
partial-onset seizures.
Sterling and Wilson Renewable Energy: Promoter Shapoorji Pallonji and Company sold 39,14,279 equity shares or 2.06 percent stake in the renewable energy company via open market transactions at a price
of Rs 415.46 per share. However, Plutus Wealth Management LLP has bought 25 lakh shares or 1.3 percent stake in the company at a price of Rs 410 per share.
Mankind Pharma: The healthcare company has made an investment of 999,900 pounds in Actimed Therapeutics for an additional 1.29 percent stake. After this investment, the aggregate shareholding of the company in Actimed will be 10.19 percent. It is a strategic investment in the field of treatment of cancer cachexia, amyotrophic lateral sclerosis, and other muscle-wasting disorders.
Lupin: The pharma major has received approval from the United States Food and Drug Administration (US FDA) for its abbreviated new drug application for Allopurinol tablets USP, 100 mg and 300 mg to market a
generic equivalent to the reference listed drug (RLD), Zyloprim tablets, of Casper Pharma LLC.
Granules India: The US FDA has completed a GMP inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the company, in Virginia, USA, during December 11–15, with five observations. Granules Pharmaceuticals does not
anticipate any disruptions to its business.
Insecticides (India): The Government of India, The Patent Office, has granted the patent for an invention to Insecticides (India) entitled A Novel Isoxazole Compound or a Salt Thereof for 20 years with effect from November 29, 2018, i.e., the date of filing.
J Kumar Infraprojects: Ace investor Sunil Singhania-owned Abakkus has bought an additional 1.32 percent stake in the construction engineering company via open market transactions
KFin Technologies: Foreign promoter General Atlantic Singapore Fund Pvt Ltd has sold 1.7 crore equity shares, equivalent to nearly 10 percent of paid-up equity, in KFin, the registrar and transfer agency in the financial sector, via open market transactions. These shares were sold at a price of Rs 500.5 per share, valued at Rs 850.85 crore.
IPO ARENA
No comments:
Post a Comment